Approximately 14 states Medicaid programs cover any form of a GLP-1 drug to treat obesity
operations at Novo Nordisk How Oral Wegovy Changes the GLP-1 Landscape For patients, the approval expands how obesity can be treated
This finding is potentially important because there are no medications currently approved for both alcohol reduction and smoking cessation
Han L, Zhang Q, Shi C, Leverson JD, Dail M, Phillips DC, Chen J, Jin SS, Jacamo RO, Daver N, Jabbour EJ, Kantarjian HM, Andreeff M , Sampath D, Konopleva M
This helps ensure the powder dissolves easily and reduces the risk of damaging the compound with a sudden temperature change
Real-world study of adverse events associated with triptan use in migraine treatment based on the U.S